Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma (EJSO 2002; 28: 673-678) [1]

European Journal of Surgical Oncology

Volumn 29, Issue 8, 2003, Pages 699-

  Trost, O ^a   Danino, A M ^a   Dutronc, Y ^a   Dalac, S ^a   Lambert, D ^a   Malka, G ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; EXCISION; GENERAL ANESTHESIA; HOSPITALIZATION; HUMAN; LETTER; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; MORBIDITY; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; SENTINEL LYMPH NODE BIOPSY; SOCIOECONOMICS; SURGICAL TECHNIQUE; WOUND DRESSING; WOUND HEALING;

EID: 0346997022     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00145-8     Document Type: Letter

References (6)

1. Blumenthal R, Banic A, Brand CU, Ris HB, Lardinois D. Morbidity and outcome after sentinel lymph node dissection patients with early staged malignant cutaneous melanoma. Swiss Surg 2002; 8(5): 209-14.
2. Rayatt SS, Hettiaratchy SP, Key A, Powell BW. Psychological benefits of sentinel lymph node biopsy in the management of cutaneous malignant melanoma. Br J Plast Surg 2002; 55(2): 95-9.
3. Dubois RW, Swetter SM, Atkins M. Developping indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma. Arch Dermatol 2001; 121.
4. Agarwala SS, Kirkwood JM. Up date on adjuvant interferon therapy for high risk melanoma. Oncology 2002; 16(9): 1177-87. Discussion 1190-1192, 1197.
5. Starz H, De Donno A, Balda BR. The Augsburg experience: histological aspects and patients outcome. Ann Surg Oncol 2001; 8: 48S-51S.
6. Carcoforo P, Soliani G, Bergossi L. Reliability and accuracy of sentinel node biopsy in cutaneous malignant melanoma. Tumori 2002; 88(3): S14-S16.